Proactive Investors

Proactive Investors

Proactiveinvestors is a prominent multimedia news company, an investor platform, and an events management firm, with locations in New York, Sydney, Toronto, Frankfurt, and London. This organization runs five financial websites in four different languages, delivering up-to-the-minute news, insights, and analysis on numerous publicly traded companies worldwide every day. We are among the fastest-growing financial media platforms globally. Additionally, Proactiveinvestors hosts highly successful "investor forums," where three to four companies showcase their offerings to a select audience of affluent investors, fund managers, hedge funds, private client brokers, and analysts.

International, Trade/B2B
English
Online/Digital

Outlet metrics

Domain Authority
66
Ranking

Global

#387206

United States

#263376

Finance/Investing

#2418

Traffic sources
Monthly visitors

Articles

  • 1 week ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

    MiningUranium This record is published on behalf of Standard Uranium Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022.

  • 1 week ago | proactiveinvestors.com | Emily Jarvie

    FinanceBlockchain & Crypto This record is published on behalf of Fineqia International Inc, a paid client of ProactiveAbout this content Disclaimer No investment advice About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022.

  • 1 week ago | proactiveinvestors.com | Angela Harmantas

    NanoViricides (NYSE-A:NNVC) said its experimental antiviral drug NV-387 could play a role in combating emerging threats from COVID-19 and bird flu, as new virus variants raise global health concerns. The company pointed to the rise of the COVID variant NB.1.8.1, or "Nimbus," which is spreading in the US and globally.

  • 1 week ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

    Peru is ramping up efforts to cement its role as a global mining powerhouse, forecasting $4.8 billion in new investment in 2025 as demand for copper and other critical minerals accelerates. The Energy and Mines Ministry expects output to rise in 2025, as global producers and junior miners double down on one of the world's richest copper reserves. Copper output is expected to rise to 2.8 million metric tons this year.

  • 1 week ago | proactiveinvestors.com | Emily Jarvie

    Lisata Therapeutics Inc (NASDAQ:LSTA) and GATC Health have expanded their strategic alliance aimed at accelerating and improving the success rate of drug development using artificial intelligence (AI). The expanded collaboration builds on prior work in which GATC provided AI-based analysis supporting Lisata’s certepetide drug candidate.